Promoters and their uses

By introducing polynucleotides with specific nucleotide substitutions into Corynebacterium microorganisms, promoter activity is enhanced, and gene expression cassettes are formed, solving the problem of low amino acid production efficiency in existing technologies and achieving high-yield and cost-effective amino acid production.

CN115698046BActive Publication Date: 2026-11-10CJ CHEILJEDANG CORP
View PDF 13 Cites 0 Cited by

Patent Information

Application Number
CN202180005398.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-05-20
Filing Date
2021-11-12
Publication Date
2026-11-10
Estimated Expiration
2041-11-12

AI Technical Summary

Technical Problem

In the existing technology, Corynebacterium microorganisms have low production efficiency when producing amino acids such as L-lysine, L-threonine, O-acetylhomoserine, L-isoleucine, L-tryptophan, L-tyrosine and L-phenylalanine, and it is difficult to achieve high-yield production through universal promoters.

Method used

A promoter-active polynucleotide was developed, which enhances promoter activity by nucleotide substitution at a specific position in the polynucleotide sequence of SEQ ID NO: 1 and is operatively linked to a target gene to form a gene expression cassette, which is then introduced into host cells to improve the productivity of target materials.

Benefits of technology

By improving promoter activity, the production volume of the target material was increased, production costs were reduced, and production convenience was improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

This application relates to a novel promoter and a method for producing target materials using the promoter. More specifically, this application relates to novel polynucleotides with promoter activity, gene expression cassettes, and host cells containing the polynucleotides, as well as a method for producing target materials using the microorganism.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This application relates to promoters and methods for producing target materials using the promoters. More specifically, this application relates to polynucleotides with promoter activity, vectors containing the polynucleotides, host cells, and methods for producing target materials using microorganisms. Background Technology

[0002] Processes for producing target materials (e.g., amino acids) from microorganisms have been investigated as environmentally friendly and safe production methods. Among these, continuous research is being conducted to produce large quantities of target materials in Corynebacterium spp. Corynebacterium spp., specifically Corynebacterium glutamicum, are Gram-positive microorganisms widely used in the production of L-amino acids and other useful materials. Various studies are underway to develop microorganisms with high-efficiency production processes and technologies for fermentation processes in order to produce L-amino acids and other useful materials.

[0003] L-Lysine is a representative material produced by Corynebacterium microorganisms for use in animal feed, human pharmaceuticals, and cosmetics industries, and is produced by fermentation using Corynebacterium strains. Microorganisms with enhanced L-lysine biosynthesis-related genes and methods for producing L-lysine using these microorganisms are known in the art (KR 10-0924065 B1).

[0004] In addition, L-threonine is an essential amino acid widely used in feed and food additives, as well as in medical infusions and as a pharmaceutical raw material. Due to its low plant protein content, L-threonine is effectively used as an animal feed additive. L-threonine is primarily produced through fermentation using *Escherichia coli* or *Corynebacterium* microorganisms developed through artificial mutation or gene recombination. Typically, methods for producing L-threonine using recombinant strains by introducing the threonine operon from *E. coli* into *Brevibacterium flavum*, threonine-producing strains, etc., are known in the art (TURBA E, et al.). Agric. Biol. Chem. 53:2269-2271, 1989).

[0005] O-acetylhomoserine is a precursor for methionine production and an intermediate in the methionine biosynthetic pathway (WO 2008 / 013432). O-acetyl-L-homoserine is synthesized from L-homoserine and acetyl-CoA as substrates via homoserine O-acetyltransferase.

[0006] L-Isoleucine shares a major biosynthetic pathway with other branched-chain amino acids, L-valine, and L-leucine. Regarding the biosynthetic pathway of L-isoleucine, 2-ketobutyrate, produced from L-threonine, is used as a precursor. L-threonine is an amino acid derived from pyruvate and aspartate produced in glycolysis. These two precursors are converted to 2-acetyl-2-hydroxyacetic acid by acetylhydroxy acid synthase (AHAS), which then produces 2,3-dihydroxy-3-methylvalerate via acetylhydroxy acid isomer reductase. Subsequently, 2-keto-3-methylvalerate is generated by dihydroxy acid dehydratase, and finally L-isoleucine is produced via transaminase. Furthermore, acetylhydroxy acid synthase catalyzes the decarboxylation of pyruvate and its condensation with other pyruvate molecules to produce acetyllactic acid, a precursor to valine and leucine.

[0007] L-Tryptophan is an essential amino acid widely used in feed additives, as a raw material for intravenous infusions and other pharmaceuticals, and as a material for health foods. Currently, L-Tryptophan is mainly produced through direct fermentation by microorganisms.

[0008] L-Tyrosine is an amino acid used as an important raw material in pharmaceuticals, food additives, animal feed, and nutritional supplements. To produce L-tyrosine and other useful materials, various studies are underway to develop microorganisms with high-efficiency production processes and technologies for fermentation. The microbial L-tyrosine production process begins with 3-deoxy-D-arabinohepetulose-7-phosphate (DAHP), produced by the polymerization of phosphoenolpyruvate (PEP), an intermediate of glycolysis, and erythrose-4-phosphate (E4P), an intermediate of the pentose phosphate pathway. DAHP is then biosynthesized from branched acid to prephenylacetic acid via a common aromatic biosynthetic pathway, and finally converted to L-tyrosine via the L-tyrosine biosynthetic pathway. During this process, branched acid can be fractionated to L-tryptophan, and prephenylacetic acid can be fractionated to L-tyrosine or L-phenylalanine. Therefore, when the common aromatic biosynthetic pathway is enhanced to increase L-tyrosine production, the production of both L-tryptophan and L-phenylalanine can be expected to increase simultaneously. In other words, phenylalanine and tryptophan are produced together as byproducts in order to produce L-tyrosine, therefore, various studies such as gene recombination and purification are necessary. Furthermore, it is known that L-tryptophan production can be regulated by repressors and attenuators based on the concentration of L-tryptophan produced by microorganisms (Korean Patent No. 10-0792095).

[0009] L-Phenylalanine is the starting material for L-aspartic-L-phenylalanine methyl ester, which is a sweetener.

[0010] If a universal promoter is developed that is not limited to specific useful materials, it is expected that it can be used to produce a variety of useful materials.

[0011] In this context, the inventors developed a polynucleotide with promoter activity that enables the high-yield production of the target material in Corynebacterium microorganisms and demonstrated that the production rate of the target material can be improved by introducing the polynucleotide into the microorganisms, thereby completing this application. Summary of the Invention

[0012] [Technical Issues] The inventors have made extensive efforts to prepare polynucleotides with promoter activity, and the results have confirmed that target gene promoters can be enhanced by nucleotide substitution, and that the enhanced promoters can regulate the expression of genes operatively linked to the promoter, thereby completing this application.

[0013] [Technical Solution] One object of this application is to provide a polynucleotide with promoter activity, wherein the nucleotides at positions 218, 219, 220, 221, 222, 225 and 227 of the polynucleotide sequence of SEQ ID NO: 1 are replaced by other nucleotides.

[0014] Another objective of this application is to provide a gene expression cassette comprising: a polynucleotide; and a gene encoding a target protein operatively linked to the polynucleotide.

[0015] Another objective of this application is to provide a host cell comprising: a polynucleotide; and a gene encoding a target protein operatively linked to the polynucleotide.

[0016] Another object of this application is to provide a method for producing a target material, comprising: culturing host cells in a culture medium; and recovering the target material from the culture medium.

[0017] Another object of this application is to provide the use of a polynucleotide as a promoter, wherein the nucleotides at positions 218, 219, 220, 221, 222, 225 and 227 of the polynucleotide sequence of SEQ ID NO: 1 are replaced by other nucleotides.

[0018] [Beneficial Effects] The promoters of this application can be introduced into microorganisms used to produce the target material to increase the yield of the target material by the microorganisms. Due to the improved production yield, industrial applications can expect benefits such as reduced production costs and ease of production. Detailed Implementation

[0019] This application will now be described in detail. Furthermore, each description and embodiment disclosed herein can be applied to other descriptions and embodiments. That is, all combinations of the various elements disclosed herein fall within the scope of this application. Further, the scope of this application is not limited to the specific descriptions below.

[0020] Furthermore, those skilled in the art can identify or confirm many equivalents of the specific aspects of the invention described herein using only conventional experiments. Moreover, it is intended that these equivalents be included in this application.

[0021] One aspect of this application provides a polynucleotide with promoter activity.

[0022] Specifically, the promoter-active polynucleotide of this application may be a promoter-active polynucleotide comprising at least one nucleotide substituted in the polynucleotide sequence of SEQ ID NO: 1.

[0023] As used herein, the term "polynucleotide" refers to a DNA chain of length exceeding a certain length, which is a long chain of nucleotide monomers linked by covalent bonds, and is a nucleotide polymer.

[0024] As used herein, the term "promoter" refers to a non-translated nucleotide sequence located upstream of a coding region that includes a polymerase binding site and has transcription initiation promoter-target gene activity, meaning that the DNA region that initiates transcription of a specific gene when bound by a polymerase. Promoters can be located in the 5' region of the mRNA transcription start site.

[0025] As used herein, the term "promoter-active polynucleotide" refers to a DNA region present near a region involved in the transcription of a target gene, which includes a binding site for an RNA polymerase or enhancer for the expression of a gene operatively linked downstream thereto, i.e., the target gene. For the purposes of this application, polynucleotides can be used as promoters for general purposes. Furthermore, compared to existing promoters or intracellular promoters, polynucleotides can regulate (e.g., increase or decrease) the expression of their operatively linked target genes and the production and / or activity of proteins encoded by the target genes in cells, and can regulate (e.g., increase or decrease) the production and / or activity of target products involved in the production of proteins (as bioactive materials, e.g., selected from at least one of amino acids, nucleic acids, vitamins, proteins, fatty acids, and organic acids), but are not limited thereto.

[0026] For example, the promoter-active polynucleotide of this application can be used as a promoter capable of enhancing the expression of peptides with transketolase (TKT) activity. Additionally, the polynucleotide can be a polynucleotide involved in increasing the production or yield of lysine, threonine, O-acetylhomoserine, isoleucine, tryptophan, tyrosine, or phenylalanine.

[0027] The polynucleotides in this application may include, but are not limited to, any polynucleotide sequence having promoter activity.

[0028] In one instance, the promoter-active polynucleotide of this application may include a promoter-active polynucleotide in which at least one nucleotide in the nucleotide sequence of SEQ ID NO: 1 is substituted by another nucleotide. Specifically, in this application, the promoter-active polynucleotide may be a promoter-active polynucleotide comprising substitutions of one or more, two or more, three or more, four or more, five or more, six or more, or seven or more nucleotides in the polynucleotide sequence of SEQ ID NO: 1. In this application, the term "promoter-active polynucleotide" may be used interchangeably with "modified promoter," and all of the foregoing terms may be used herein.

[0029] In this application, the polynucleotide sequence of SEQ ID NO: 1 can be, for example, a polynucleotide with transketolase promoter activity. Additionally, the polynucleotide in which a specific nucleotide is substituted in the polynucleotide sequence of SEQ ID NO: 1 can also be a polynucleotide with transketolase promoter activity, as long as it possesses promoter activity. The polynucleotide sequence of SEQ ID NO: 1 can be a representative polynucleotide used to indicate the mutation site, and other corresponding polynucleotide sequences with promoter activity are also included in the sequences from which mutations can be introduced. For example, any polynucleotide sequence capable of acting as a promoter for transketolase (TKT) or any polypeptide with corresponding activity can be included in the scope of sequences from which mutations can be introduced in this application, but is not limited thereto.

[0030] The nucleotide sequence of SEQ ID NO: 1 can be identified from the known database NCBI GenBank, and the sequence corresponding to SEQ ID NO: 1, as a sequence that can be used as a promoter for transketolase, can be derived from a certain species of Corynebacterium, and specifically, can be a sequence of Corynebacterium glutamicum. However, the promoter of this application may contain a sequence with equivalent or higher activity than the polynucleotide, but is not limited thereto.

[0031] The promoter-active polynucleotide of this application may be a polynucleotide in which promoter activity is enhanced by nucleotide substitution at a specific position in a polynucleotide sequence in which promoter activity exists.

[0032] In one embodiment, the promoter-active polynucleotide of this application may include a promoter-active polynucleotide wherein at least one nucleotide in the nucleotide sequence of SEQ ID NO: 1 is substituted by another nucleotide. Specifically, it may consist of a promoter-active polynucleotide wherein at least one nucleotide in the nucleotide sequence of SEQ ID NO: 1 is substituted by another nucleotide. In this application, the term "promoter-active polynucleotide" may be used interchangeably with "modified promoter".

[0033] In one embodiment, the modified promoter can be a polynucleotide with promoter activity, including at least one nucleotide in which a nucleotide selected from positions 218, 219, 220, 221, 222, 225, and 227 is replaced by another nucleotide. Specifically, the modified promoter can be a promoter in which any one or more, two or more, three or more, four or more, five or more, six or more, or seven of the aforementioned positions or their corresponding positions are replaced by other nucleotides.

[0034] As used herein, the term "another / other nucleotide" is not limited as long as it is different from the nucleotide before substitution. For example, when describing "the nucleotide at position 218 of SEQ ID NO: 1 is substituted by another nucleotide," it means that it is substituted by adenine (A), thymine (T), or guanine (G), except for cytosine (C). Furthermore, unless otherwise stated, when describing a specific nucleotide as being "substituted," it means that the nucleotide is substituted by another nucleotide that is different from the nucleotide before substitution.

[0035] Furthermore, those skilled in the art can identify, through sequence alignment known in the art, the nucleotides at positions corresponding to nucleotides 218, 219, 220, 221, 222, 225, and 227 of SEQ ID NO: 1 in any polynucleotide sequence. Further, unless otherwise stated herein, when describing "nucleotide at a specific position in a specific SEQ ID NO," it obviously refers to "nucleotide at the corresponding position" in any polynucleotide sequence. Therefore, polynucleotide sequences in which any one or more nucleotides selected from the nucleotides corresponding to positions 218, 219, 220, 221, 222, 225, and 227 of SEQ ID NO: 1 in any promoter-active polynucleotide sequence are also within the scope of this application.

[0036] In one instance, when one or more, two or more, three or more, four or more, five or more, six or more, or seven nucleotides at positions 218, 219, 220, 221, 222, 225, and 227 of SEQ ID NO: 1 are replaced by other nucleotides, a promoter with higher activity than the unsubstituted (unmodified) promoter sequence can be obtained.

[0037] Specifically, the promoter-active polynucleotide of this application may be a polynucleotide in which the nucleotides at positions 218, 219, 220, 221, 222, 225 and 227 of the polynucleotide sequence of SEQ ID NO: 1 are replaced by other nucleotides, but is not limited thereto.

[0038] In a specific example, the promoter-active polynucleotide of this application may be the following polynucleotide, wherein in the polynucleotide sequence of SEQ ID NO: 1, the nucleotide cytosine (C) at position 218 is replaced by thymine (T), the nucleotide cytosine (C) at position 219 is replaced by guanine (G), the nucleotide adenine (A) at position 220 is replaced by thymine (T), the nucleotide adenine (A) at position 221 is replaced by guanine (G), the nucleotide thymine (T) at position 222 is replaced by guanine (G), the nucleotide adenine (A) at position 225 is replaced by thymine (T), and the nucleotide cytosine (C) at position 227 is replaced by adenine (A).

[0039] In a more specific instance, it can be a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2. Specifically, the promoter-active polynucleotide in this application can be a polynucleotide sequence including SEQ ID NO: 2 or a polynucleotide consisting of (substantially) thereof.

[0040] Furthermore, various modifications to the polynucleotide sequence can be included within the scope of not significantly reducing promoter activity, and are not limited to the embodiments described above. For example, the nucleotide sequence of this application can be modified by conventionally known mutagenesis, such as directed evolution, site-directed mutagenesis, etc.

[0041] Specifically, the term “modification” refers to genetically or non-genetically stable phenotypic changes and may be used interchangeably with the terms “modification” or “mutation” in this article.

[0042] Therefore, the promoter-active polynucleotide in this application can be a polynucleotide sequence having SEQ ID NO: 1 or SEQ ID NO: 2, or a polynucleotide sequence having at least 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% homology or identity with SEQ ID NO: 1 or SEQ ID NO: 2. The homologous or identical nucleotide sequence can be a sequence within the above range, excluding sequences with 100% identity, or a sequence with less than 100% identity.

[0043] Furthermore, although it is described in this application as "a polynucleotide having a nucleotide sequence of a specific SEQ ID NO" or "a polynucleotide including a nucleotide sequence of a specific SEQ ID NO", it is clear that any polynucleotide in which a portion of the nucleotide sequence is deleted, modified, substituted, or added may also be used in this application, as long as the polynucleotide has the same or corresponding activity as the polynucleotide composed of the nucleotide sequence of the corresponding SEQ ID NO.

[0044] For example, as long as the polynucleotide has the same or corresponding activity as the polynucleotide, it is obvious that a polynucleotide in which a meaningless sequence is added within or at the end of the nucleotide sequence of the corresponding SEQ ID NO, or a polynucleotide in which a sequence is missing within or at the end of the nucleotide sequence of the corresponding SEQ ID NO, also falls within the scope of this application.

[0045] As used in this article, the term “homology” or “identity” refers to the degree of correlation between two given nucleotide sequences and can be expressed as a percentage.

[0046] Terms of cognateness and identity are often used interchangeably.

[0047] Sequence homology or identity of conserved polynucleotides can be determined using standard alignment algorithms and can be used in conjunction with default gap penalties established by the procedure used. Essentially, homologous or identical sequences can hybridize under moderately or highly stringent conditions, such that at least about 50%, 60%, 70%, 80%, or 90% or more of the full length of the sequence can hybridize. Polynucleotides containing degenerate codons instead of codons in the hybridized polynucleotides are also considered.

[0048] Whether any two polynucleotide sequences are homologous, similar, or identical can be determined, for example, by known computer algorithms such as the “FASTA” program (Pearson et al., (1988)). Proc. Natl. Acad. Sci. USA85:2444) uses default parameters to determine. Alternatively, it can be determined using the Needleman program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice). et al. , 2000, Trends Genet. 16:276-277) (Preferably version 5.0.0 or later) (GCG package (Devereux, J.) et al. , Nucleic Acids Research 12:387 (1984)) executed the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48:443-453), BLASTP, BLASTN, FASTA (Atschul, SF et al., J MOLEC BIOL 215:403 (1990); Guide to Huge Computers Martin J. Bishop, ed., Academic Press, San Diego, 1994, and Carillo et al. (1988) SIAM J Applied Math (48:1073) to determine. For example, homology, similarity, or identity can be determined using BLAST or ClustalW from the National Center for Biotechnology Information (NCBI).

[0049] Homology, similarity, or identity of polynucleotides can be determined, for example, by using computer programs such as GAP (e.g., Needleman et al. (1970)). J Mol Biol. 48:443) Determining this by comparing sequence information, such as Smith and Waterman. Adv. Appl. Math As disclosed in (1981) 2:482. In summary, the GAP procedure defines homology, similarity, or identity as a value obtained by dividing the number of similarly aligned symbols (i.e., nucleotides or amino acids) by the total number of symbols in the shorter of the two sequences. The default parameters of the GAP procedure may include (1) a univariate comparison matrix (containing a value of 1 for identity and 0 for non-identity) and a weighted comparison matrix such as that of Gribskov et al. (1986), Nucl. Acids Res. 14:6745, as well as those of Schwartz and Dayhoff, eds. Atlas of Protein Sequence and Structure, National Biomedical Research Foundation, pp. 353-358 (1979) (or as disclosed in the EDNAFULL substitution matrix (EMBOSS version of NCBI NUC4.4); (2) a penalty of 3.0 for each vacancy, and an additional penalty of 0.10 for each symbol in each vacancy (or a vacancy opening penalty of 10 and a vacancy expansion penalty of 0.5); and (3) no penalty for terminal vacancy. Therefore, as used herein, the term “homology” or “identity” refers to the correlation between sequences.

[0050] Additionally, probes that can be prepared from known gene sequences may be included, for example, any polynucleotide sequence that, under stringent conditions, can hybridize with sequences complementary to all or part of the polynucleotide sequence and exhibit the same activity. "Stringent conditions" refers to conditions under which specific hybridization between polynucleotides is permitted. Such conditions are specifically described in the literature (e.g., J. Sambrook et al.). Molecular Cloning, A Laboratory Manual ,2nd Edition, Cold Spring Harbor Laboratory press, Cold Spring Harbor, NewYork, 1989; FM Ausubel et al. , Current Protocols in Molecular Biology (John Wiley & Sons, Inc., New York). For example, stringent conditions may include conditions under which genes with 40% or higher, specifically 70% or higher, 80% or higher, 85% or higher, 90% or higher, more specifically 95% or higher, more specifically 97% or higher, still more specifically 99% or higher, highly homologous or identical to each other, and genes with less than the aforementioned homologous or identical to each other do not hybridize, or Southern hybridization washing conditions, i.e., washing once, specifically twice or three times, at salt concentrations and temperatures corresponding to 60°C, 1×SSC, 0.1% SDS, specifically 60°C, 0.1×SSC, 0.1% SDS, and more specifically 68°C, 0.1×SSC, 0.1% SDS.

[0051] Hybridization requires two nucleic acids to contain complementary sequences, although mismatches between bases may exist, depending on the stringency of the hybridization process. The term "complementary" is used to describe the relationship between nucleotide bases that can hybridize with each other. For example, in DNA, adenine is complementary to thymine, and cytosine is complementary to guanine. Therefore, this application may include isolated nucleotide fragments complementary to the whole sequence as well as nucleic acid sequences substantially similar to them.

[0052] Specifically, polynucleotides with homology or identity can be used, including those containing T under the above conditions. m The hybridization conditions, with a value of 55℃, were used for detection. Furthermore, T... m The value can be 60℃, 63℃ or 65℃, but is not limited to these, and those skilled in the art can adjust it appropriately according to their purpose.

[0053] The appropriate stringency for hybrid polynucleotides depends on the length and complementarity of the polynucleotides, and these variables are well known in the art (see Sambrook et al., ibid., 9.50–9.51, 11.7–11.8).

[0054] The promoter-active polynucleotides of this application can be isolated or prepared using standard molecular biology techniques. For example, they can be prepared using standard synthesis techniques with an automated DNA synthesizer, but are not limited thereto.

[0055] The polynucleotides with promoter activity described in this application can be used as promoters.

[0056] The promoter can be located in the 5' region of the transcription start site within the mRNA.

[0057] Compared to conventional promoters, this promoter can have increased or decreased promoter activity. That is, the promoter can increase or decrease the expression and / or activity of the protein encoded by the target gene, as well as the expression of the target gene in the host cell. For the purposes of this application, the target gene used for enhanced or weakened expression can be changed according to the product to be produced, and the promoter can be used as a universal promoter for enhancing or weakening the target gene.

[0058] Another aspect of this application provides a gene expression cassette comprising the polynucleotide and a target gene.

[0059] The polynucleotides in this application are as described above.

[0060] As used herein, the term "gene expression cassette" refers to a unit box containing a promoter and a target gene, thus enabling the expression of the target gene operatively linked downstream of the promoter. Such a gene expression cassette may include various factors that can help to effectively express the target gene, either inside or outside the cassette. In addition to a promoter operatively linked to the target gene, a gene expression cassette typically includes, but is not limited to, transcription termination signals, ribosome-binding domains, and translation termination signals.

[0061] As used herein, the term "target gene" refers to a gene whose expression is controlled by the promoter sequence of this application for the purposes of this application. A protein encoded by a target gene may be referred to as a "target protein," and a gene encoding a "target protein" may be referred to as a "target gene."

[0062] Furthermore, due to codon degeneracy or considering preferred codons in organisms expressing the polynucleotides of this application, the polynucleotide encoding the target protein can be modified in various ways in the coding region without altering the polypeptide sequence. The polynucleotide sequence is as described above.

[0063] In one embodiment, the target protein may be a polypeptide with transketolase (TKT) activity. That is, the target gene of the promoter may be a gene encoding a polypeptide with transketolase (TKT) activity.

[0064] As used herein, the term "transketolase" refers to an enzyme that affects the pentose phosphate pathway and produces D-sedoheptulose-7-phosphate and D-glyceraldehyde-3-phosphate from D-xylitolose-5-phosphate and D-ribose-5-phosphate. By modulating its activity, the yield of useful materials such as lysine, threonine, O-acetylhomoserine, isoleucine, tryptophan, tyrosine, and phenylalanine can be enhanced.

[0065] Examples of genes encoding transketolases include Corynebacterium glutamicum ATCC13032, etc. tkt The gene (NCgl1512), but not limited thereto. Those skilled in the art can readily obtain information on genes encoding transketolases from known databases such as GenBank.

[0066] In addition, the amino acid sequences that make up transketolases can be obtained from the known database NCBI's GenBank. For example, it can be derived from Corynebacterium glutamicum.

[0067] Furthermore, the “polypeptide with transketolase activity” in this application includes not only wild-type, unmodified, or natural forms of transketolase, but also mutants with the same or enhanced activity.

[0068] As used herein, “modified polypeptide” and “variant” have the same meaning, referring to a protein that has one or more amino acids that differ from the said sequence through conserved substitution and / or modification, thereby retaining the protein’s function and properties.

[0069] These variants differ from sequences identified by substitution, deletion, or addition of several amino acids. Such variants are typically identified by modifying one or more of the aforementioned amino acid sequences of a protein and assessing the properties of the modified protein. That is, the ability of the variant can be enhanced relative to the native protein. Furthermore, some variants may include those in which one or more portions (e.g., the N-terminal leader sequence or transmembrane domain) have been removed.

[0070] The term "variant" may be used interchangeably with terms such as modification, modified protein, modified peptide, mutant, mutant protein, divergent, variant, etc., as long as these terms are used to indicate variation. For the purposes of this application, a variant may be, but is not limited to, a variant of a modified protein that exhibits enhanced activity compared to the activity of a natural wild-type or unmodified protein.

[0071] As used herein, the term "conservative substitution" refers to the substitution of an amino acid with another amino acid having similar structure and / or chemical properties. This variant may have, for example, at least one conserved substitution while retaining at least one biological activity. Such amino acid substitution can typically occur based on the similarity of the residues' polarity, charge, solubility, hydrophobicity, hydrophilicity, and / or amphiphilic properties.

[0072] Furthermore, variants can also include the deletion or addition of amino acids that have minimal impact on the properties and secondary structure of the polypeptide. For example, the polypeptide can be conjugated at its N-terminus to a signal (or leader) sequence involved in co-translation or post-translational protein transfer. Further, the polypeptide can be conjugated to another sequence or linker to identify, purify, or synthesize the polypeptide.

[0073] The gene encoding the polypeptide with transketolase activity of this application may be referred to as " tkt Gene".

[0074] This gene can originate from Corynebacterium genus microorganisms, specifically from Corynebacterium glutamicum.

[0075] In this application, due to codon degeneracy or considering preferred codons in organisms expressing polypeptides, the encoding of " tkt A "gene" is a polynucleotide of a polypeptide with transketolase activity, which can be modified in various ways in the coding region without altering the polypeptide sequence.

[0076] The polypeptides of this application having transketolase activity may include variant sequences, and may specifically include variants of modified proteins that can express enhanced transketolase activity.

[0077] Another aspect of this application provides a recombinant vector—which includes a polynucleotide or a gene expression cassette—which includes a gene encoding a target protein operatively linked to the polynucleotide.

[0078] The polynucleotides, target proteins, and gene expression cassettes of this application are as described above.

[0079] In one embodiment, the target protein may be a polypeptide with transketolase activity.

[0080] As used herein, the term "vector" is an artificial DNA molecule that has genetic material that enables the expression of a target gene in a suitable host cell, specifically a DNA construct that includes a nucleotide sequence of a gene encoding a target protein that is operatively linked thereto.

[0081] As used herein, the term "operably ligated" refers to the functional ligation of a polynucleotide having the promoter activity of this application to a gene sequence, thereby enabling the initiation and mediation of transcription of a target gene. Operable ligations can be prepared using gene recombination techniques known in the art, and site-specific DNA cutting and ligation can be prepared using cutting and ligases known in the art, but are not limited thereto.

[0082] For the purposes of this application, the regulatory sequence may include the promoter-active polynucleotide of this application.

[0083] Simultaneously, regulatory sequences may include promoters capable of initiating transcription, any operon sequences used to regulate such transcription, sequences encoding appropriate mRNA ribosome-binding domains, and sequences used to regulate transcription and translation. Once transformed into a suitable host cell, the vector can replicate or function independently of the host genome, or it can integrate into its genome.

[0084] The vectors used in this application are not specifically limited, as long as the vector can be expressed in host cells and any vector known in the art can be used to transform host cells. Examples of commonly used vectors may include natural or recombinant plasmids, granules, viruses, and bacteriophages.

[0085] For example, pWE15, M13, MBL3, MBL4, IXII, ASHII, APII, t10, t11, Charon4A, and Charon21A can be used as phage vectors or granular vectors; vectors based on pDZ, pBR, pUC, pBluescriptII, pGEM, pTZ, pCL, and pET can be used as plasmid vectors, but the vectors are not limited to these. Specifically, pDZ, pDC, pDCM2, pACYC177, pACYC184, pCL, pECCG117, pUC19, pBR322, pMW118, and pCC1BAC vectors can be used, but the vectors are not limited to these. Polynucleotide insertion into chromosomes can be performed using methods known in the art, such as homologous recombination.

[0086] Since the vector of this application can be inserted into chromosomes via homologous recombination, it can further include selection markers for confirming the insertion into the chromosome. The selection markers are used to select transformed cells, i.e., to confirm the insertion of the polynucleotide, and can use markers capable of providing selectable phenotypes such as drug resistance, nutritional requirements, resistance to cytotoxic agents, or surface protein expression. Under selection agent treatment, only cells capable of expressing the selection marker can survive or express other phenotypic traits, thereby selecting transformed cells.

[0087] As used herein, the term "transformation" refers to the process of introducing a vector containing a polynucleotide encoding a target protein into a host cell, thereby enabling the protein encoded by the polynucleotide to be expressed in the host cell. It is irrelevant whether the transformed polynucleotide is inserted into or outside the host cell's chromosome, as long as it can be expressed in the host cell. Furthermore, the polynucleotide can include DNA and RNA encoding the target protein and can be introduced in any form, as long as it can be introduced into the host cell and expressed therein. For example, the polynucleotide can be introduced in the form of an expression cassette, which is a gene construct containing all the necessary elements for self-expression; or in the form of a vector comprising the expression cassette.

[0088] The transformation method can include any method that can introduce a gene encoding a target protein into a cell, and can be performed by selecting appropriate standard techniques known in the art based on the host cell. For example, the method can include, but is not limited to, electroporation, calcium phosphate (CaPO4) precipitation, calcium chloride (CaCl2) precipitation, microinjection, polyethylene glycol (PEG) method, DEAE-dextran method, cationic liposome method, and lithium acetate-DMSO method.

[0089] Another aspect of this application provides a host cell comprising: the polynucleotide, and a gene encoding a target protein operatively linked to the polynucleotide.

[0090] Specifically, the host cell can be a microorganism of the genus Corynebacterium, more specifically, Corynebacterium glutamicum, but not limited thereto.

[0091] Polynucleotides and target proteins are as described above.

[0092] As used herein, the term "microbe" is a concept that includes both wild-type microbes and naturally or artificially genetically modified microbes, and can be a microbe with a specific weakening or strengthening mechanism due to the insertion of exogenous genes or the enhancement or weakening of the activity of endogenous genes. Specifically, it can be a microbe containing polynucleotides and target proteins with promoter activity.

[0093] The target protein can be a polypeptide with transketolase (TKT) activity. The promoter-active polynucleotide, target protein, transketolase (TKT) active polypeptide, and carrier are as described above.

[0094] The microorganisms can be of the genus Corynebacterium, more specifically Corynebacterium glutamicum, but are not limited thereto.

[0095] The microorganism may be a microorganism expressing transketolase, a microorganism expressing a polypeptide with transketolase activity, or a microorganism with a polypeptide having transketolase activity introduced, but is not limited thereto.

[0096] In this application, the microorganism may include the promoter-active polynucleotide of this application, specifically including the polynucleotide and / or a gene encoding a target protein operatively linked to the polynucleotide. Optionally, the microorganism may include a vector containing a polynucleotide or a gene encoding a gene expression regulatory sequence and a target protein, but is not limited thereto. Furthermore, the polynucleotide, the gene encoding the target protein, and the vector may be introduced into the microorganism through transformation, but is not limited thereto. Further, as long as the gene can be expressed, it does not matter whether the gene encoding the polynucleotide and the target protein is located on a chromosome or extrachromosomally.

[0097] As used herein, the term "expressed" in relation to proteins refers to the state in which a target protein, such as a transketolase or a variant thereof, is introduced into a microorganism or modified to be expressed in a microorganism. When the target protein is a protein present in a microorganism, the term refers to a state in which the activity of the protein is enhanced compared to that of its endogenous counterpart or its unmodified form.

[0098] Specifically, the term "introduction of a protein" refers to a microorganism exhibiting the activity of a specific protein that it did not originally possess, or exhibiting enhanced activity compared to its endogenous activity or the activity of the protein before modification. For example, it might mean introducing a polynucleotide encoding a specific protein into the chromosome of a microorganism; or introducing a vector containing a polynucleotide encoding a specific protein into a microorganism, thereby allowing the expression of the specific protein's activity.

[0099] Furthermore, the term "enhanced activity" refers to an increase in the activity of a specific protein in a microorganism compared to its endogenous activity or its activity before modification. The term "endogenous activity" refers to the activity of a specific protein originally possessed by the parent strain before modification, when the microbial trait has been altered due to genetic mutations caused by natural or anthropogenic factors.

[0100] For the purposes of this application, the activity can be enhanced by using the promoter-active polynucleotide sequence of this application as an expression regulatory sequence for the target protein. Since the target protein can be a natural protein or a modified protein as described above, the expression regulatory sequence can be an expression regulatory sequence of a gene encoding a protein variant, or an expression regulatory sequence of a gene encoding a natural protein on a chromosome.

[0101] In addition, other methods for enhancing activity can be used in combination. For example, in addition to using the promoter-active polynucleotide of this application as the expression regulatory sequence of the target protein, any one or more methods selected from the following can be used: methods for increasing the intracellular copy number of the gene encoding the target protein; methods for replacing the gene encoding the native protein on the chromosome with the gene encoding the protein variant; methods for further introducing mutations into the gene encoding the protein to enhance the activity of the protein variant; and methods for introducing the protein variant into microorganisms, but the methods are not limited thereto.

[0102] By using the promoter-active polynucleotides of this application as expression regulatory sequences for target proteins in microorganisms, the activity of target proteins can be enhanced.

[0103] For example, based on the activity or concentration of proteins in wild-type or unmodified microbial strains, the activity or concentration of the corresponding proteins may be increased by at least 1%, 10%, 25%, 50%, 75%, 100%, 150%, 200%, 300%, 400%, or 500%, and up to 1,000% or 2,000%, but the range of increase is not limited thereto.

[0104] As used herein, the term "unmodified microorganism" does not exclude strains containing mutations that may occur naturally in microorganisms, and may be the wild-type strain itself, or may include microorganisms that do not contain the promoter-active polynucleotides of this application, or microorganisms that have not been transformed with a vector containing the promoter-active polynucleotides of this application.

[0105] As used herein, "microorganisms for producing target materials" includes all naturally or artificially genetically modified microorganisms, and can be microorganisms in which a specific mechanism is weakened or enhanced due to the insertion of exogenous genes or the enhancement or inactivation of endogenous genes, and can be microorganisms in which genetic modifications are performed to produce the desired product or enhance activity. For the purposes of this application, microorganisms for producing target materials can refer to microorganisms capable of overproducing target materials compared to wild-type or unmodified microorganisms, including the promoter-active polynucleotides of this application.

[0106] "Microorganisms used to produce target materials" can be used interchangeably with "microorganisms that produce target materials", "microorganisms with the ability to produce target materials", "strains that produce target materials", and "strains with the ability to produce target materials".

[0107] The target material can be an amino acid, specifically lysine, threonine, O-acetylhomoserine, isoleucine, tryptophan, tyrosine, or phenylalanine. In more specific examples, lysine can be L-lysine, threonine can be L-threonine, O-acetylhomoserine can be O-acetyl-L-homoserine, isoleucine can be L-isoleucine, tryptophan can be L-tryptophan, tyrosine can be L-tyrosine, and phenylalanine can be L-phenylalanine, but the target material is not limited to these.

[0108] For the purposes of this application, the microorganisms used to produce the target material may be those microorganisms whose ability to produce the target material, specifically lysine, threonine, O-acetylhomoserine, isoleucine, tryptophan, tyrosine, or phenylalanine, is enhanced.

[0109] Meanwhile, the microorganisms used to produce the target material can be wild-type microorganisms or recombinant microorganisms. Recombinant microorganisms are as described above. Microorganisms may further include mutations, such as enhancing biosynthetic pathways to increase the ability to produce the target material, removing feedback inhibition, or inactivating genes to weaken degradation or biosynthetic pathways, etc., and these mutations can be artificially induced, for example, through UV irradiation, but naturally occurring mutations are not excluded.

[0110] Specifically, microorganisms used to produce the target material can be mutated to enable them to produce the target material. For example, this could be microorganisms that lack the ability to produce the target material but are mutated to possess that ability, or it could be microorganisms with enhanced production capabilities. For instance, it could be a microorganism in which proteins or variants thereof involved in the biosynthetic pathway are introduced, enabling the production of the target material in wild-type microorganisms (KR 10-2011994, KR 10-1947959).

[0111] The microorganisms of this application, compared with microorganisms that do not contain polynucleotides with promoter activity, may have the ability to produce at least 1%, 5%, 10%, 13%, 15%, 16%, 17%, 18%, 19%, 20%, or 25% or more of the target material.

[0112] Another aspect of this application provides a method for producing a target material, including culturing host cells in a culture medium and recovering the target material from the culture medium.

[0113] The host cell and target material are as described above.

[0114] As used herein, the term "culture" refers to the growth of microorganisms in suitable, artificially controlled environmental conditions. In this application, the method for producing target materials using microorganisms containing polynucleotides can be carried out using methods known in the art. Specifically, culturing can be carried out continuously in a batch process, a fed-batch process, or a repeatedly fed-batch process, but is not limited thereto. The culture medium used for culturing must be appropriately suited to the requirements of the specific strain. Culture media for strains belonging to the genus *Corynebacterium* are known (e.g., *Manual of Methods for General Bacteriology*. *American Society for Bacteriology*. Washington DC, USA, 1981).

[0115] Examples of carbon sources can include sugars and carbohydrates, such as glucose, sucrose, lactose, fructose, maltose, starch, and cellulose; oils, such as soybean oil, sunflower oil, castor oil, and coconut oil; fatty acids, such as palmitic acid, stearic acid, and linoleic acid; alcohols, such as glycerol and ethanol; and organic acids, such as acetic acid. These carbon sources can be used alone or in combination, but are not limited to these.

[0116] Examples of nitrogen sources may include peptone, yeast extract, meat broth, malt extract, corn steep liquor (CSL), soybean flour, and urea; or inorganic nitrogen sources such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate, and ammonium nitrate. These nitrogen sources may be used alone or in combination, but are not limited thereto.

[0117] Examples of phosphorus sources may include potassium dihydrogen phosphate, dipotassium hydrogen phosphate, or their corresponding sodium-containing salts. Additionally, the culture medium may contain growth-essential metal salts, such as magnesium sulfate or ferric sulfate. Finally, growth-essential materials such as amino acids and vitamins may be used. Furthermore, appropriate precursors may be included in the culture medium. These materials can be added to the culture in batch or continuous batches using appropriate methods.

[0118] The pH of the culture can be appropriately adjusted by using alkaline compounds such as sodium hydroxide, potassium hydroxide, and ammonia, or acidic compounds such as phosphoric acid and sulfuric acid. Additionally, defoamers such as polyethylene glycol esters of fatty acids can be added to prevent foam formation. To maintain the aerobic state of the culture, oxygen or oxygen-containing gas (e.g., air) can be injected into the culture.

[0119] The temperature of the culture (culture medium) can typically be from 20°C to 45°C, preferably from 25°C to 40°C, and can be continuously cultured until the desired amount of target material is obtained, and can specifically be carried out for 10 to 160 hours.

[0120] The target material can be recovered from the culture (culture medium) by separation and recovery using conventional methods known in the art. Separation methods may include, for example, centrifugation, filtration, chromatography, and crystallization. For instance, the supernatant obtained by centrifuging the culture at low speed to remove biomass can be separated by ion-exchange chromatography, but is not limited thereto.

[0121] The recovery process may also include purification processes.

[0122] Another further aspect of this application provides the use of a polynucleotide as a promoter, wherein the nucleotides at positions 218, 219, 220, 221, 222, 225, and 227 of the polynucleotide sequence of SEQ IDNO: 1 are replaced by other nucleotides.

[0123] Polynucleotides are as described above.

[0124] [Methods of Implementing the Invention] This application will be described in detail by way of embodiments. However, it will be apparent to those skilled in the art that these embodiments are given for illustrative purposes only and are not intended to limit the scope of the invention thereto.

[0125] Example 1. Confirmation of the activity of the novel promoter in inducing target gene expression Example 1-1. Constructing a library of tkt promoter variants using random mutagenesis First, according to the National Institutes of Health GenBank, the strain containing wild-type Corynebacterium glutamicum ATCC13032 was obtained. tkt The nucleotide sequence (SEQ ID NO: 1) of the promoter region of the gene (NCBI accession number NCgl1512). The Diversify® PCR Random Mutagenesis Kit (Takara) uses the nucleotide sequence of SEQ ID NO: 1. tkt Using the gene promoter (Pntkt) as a template, primers SEQ ID NO: 3 and 4 were used to induce random mutagenesis according to the manufacturer's manual, resulting in PCR products (Pmtkt) with different tkt promoter variants. Additionally, primers SEQ ID NO: 5 and 6 were used, based on the pGFPuv vector (Clontech, USA) as a template, to... GFP PCR was performed on the gene's ORF (open reading frame). Solg™ Pfu-X polymerase was used as the polymerase, and PCR was performed under the following PCR amplification conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; then polymerization at 72°C for 5 minutes to obtain the gene fragment containing the GFP-containing ORF.

[0126] The PCR product of the tkt promoter variant (Pmtkt), the amplification product, and GFP were mixed with the *E. coli*-*Corynebacterium* shuttle vector pCES208, which was digested with BamHI / SalI restriction endonuclease. J. Microbiol. Biotechnol. 18:639-647, 2008) mixed and assembled using the Gibson assembly method (DG Gibson et al., NATURE METHODS (Vol. 6 No. 5, MAY 2009, NEBuilder HiFi DNA Assembly Master Mix) Cloning was performed to obtain recombinant plasmids, each named pCES208_Pm1tkt_gfp to pCES208_Pm50tkt_gfp. Cloning was carried out by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0127] As a control used to confirm the activity of the tkt promoter variant library, the wild-type strain was used. tkt The gene promoter (SEQ ID NO: 1) and GFP-linked recombinant vector. Wild type tkt The promoter gene (Pntkt) was obtained using primers SEQ ID NO: 3 and 4, based on wild-type Corynebacterium glutamicum ATCC13032 as a template. Additionally, primers SEQ ID NO: 5 and 6 were used, based on the pGFPuv vector as a template, to... GFP PCR was performed using the gene's ORF (open reading frame). Solg™ Pfu-X polymerase was used as the polymerase, and PCR was performed under the following conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles of denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; then polymerization at 72°C for 5 minutes to obtain the gene fragment containing the GFP-containing ORF.

[0128] The wild-type tkt promoter variant PCR product (Pntkt), amplification product, and GFP were mixed with pCES208 digested with BamHI / SalI restriction endonucleases, and cloned using the Gibson assembly method to obtain the recombinant plasmid, named pCES208_Pntkt_gfp. Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0129] Examples 1-2. Construction of transformed strains The pCES208 vector and the recombinant vector libraries prepared in Examples 1-1, including pCES208_Pm1tkt_gfp to pCES208_Pm50tkt_gfp and pCES208_Pntkt_gfp, were subjected to electroporation. Appl. Microbiol. Biotechnol. (1999) 52:541-545) The transformed strain was transferred to Corynebacterium glutamicum ATCC13032 and then the transformed strain was obtained in selective medium containing 25 mg / L kanamycin. The strains were named ATCC13032 / pCES208, ATCC13032 / pCES208_Pm1tkt_gfp to ATCC13032 / pCES208_Pm50tkt_gfp and ATCC13032 / pCES208_Pntkt_gfp, respectively.

[0130] Examples 1-3. Selection of tkt promoter variants To confirm the activity of the tkt promoter variant, the transformed strains obtained in Examples 1-2 were cultured as follows, and GFP activity was measured.

[0131] Specifically, each transformed Corynebacterium glutamicum strain was inoculated into 25 mL of medium containing glucose (20 g, ammonium sulfate (5 g), yeast extract (5 g), urea (1.5 g), KH₂PO₄ (4 g), K₂HPO₄ (8 g), MgSO₄•7H₂O (0.5 g), biotin (150 μg), thiamine-HCl (1.5 mg), calcium pantothenate (3 mg), and nicotinamide (3 mg) (based on 1 L distilled water), pH 7.2) and cultured with shaking at 30 °C for 20 h. Bacterial cells were recovered by centrifugation (5,000 rpm, 15 min), washed twice with 50 mM Tris-HCl (pH 8.0) buffer, and resuspended in the same buffer. Glass beads were added to the suspension at a rate of 1.25 g / 1.5 mL, and the bacterial cells were pulverized using a bead beater for 6 min. The resulting material was then centrifuged (15,000 rpm, 20 min) to recover the supernatant, and protein concentration was quantified using the Bradford method. For equal volumes of bacterial cell extract, protein concentration was determined according to Laure Gory et al. (…). FEMS Microbiology Letters The method introduced in 194, 127-133, 2001, involves excitation at 488 nm and measurement of emission at 511 nm using an LS-50B spectrophotometer (Perkin-Elmer), thereby measuring... GFPGene expression levels. Results showed that, compared with the control ATCC13032 / pCES208_Pntkt_gfp strain... GFP Compared to gene expression levels, those with the highest expression levels were selected. GFP Strains with gene expression levels (Table 1).

[0132] [Table 1] As shown in Table 1, the Pm4tkt promoter was confirmed to exhibit promoter activity in Corynebacterium glutamicum and showed higher fluorescence sensitivity than the wild-type tkt promoter.

[0133] To confirm the mutation introduced into the selected Pm4tkt promoter described above, PCR was performed using primers SEQ ID NO: 7 and 8, followed by sequence analysis. The Pm4tkt promoter was compared with the wild-type tkt promoter sequence SEQ ID NO: 1 to confirm the sequence of the tkt promoter variant, and the sequences are shown in Table 2 below.

[0134] [Table 2] Example 2. Construction of a vector for introducing a Pm4tkt promoter variant Example 2-1. Construction of a vector for introducing the Pm4tkt promoter variant into Corynebacterium glutamicum ATCC13032 To construct a vector for introducing the Pm4tkt promoter variant into Corynebacterium glutamicum ATCC13032, primer pairs SEQ ID NO: 9 and 10 and SEQ ID NO: 13 and 14 were used, based on the chromosome of wild-type Corynebacterium glutamicum ATCC13032 as a template, to obtain the upstream region of the tkt promoter and the downstream region including a portion of the tkt ORF. Furthermore, using SEQ ID NO: 11 and 12, based on the pCES208_Pm4tkt_gfp vector as a template, PCR products corresponding to the promoter variant were obtained. Solg™ Pfu-X DNA polymerase was used as the polymerase, and PCR was performed under the following PCR amplification conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; then polymerization at 72°C for 5 minutes to obtain the PCR product. The three amplification products were mixed with the pDCM2 vector (Korean Patent Application Publication No. 10-2020-0136813) previously digested with the SmaI restriction endonuclease, and cloned using the Gibson assembly method to obtain the recombinant plasmid, which was named pDCM2-Pm4tkt_tkt. Cloning was performed by mixing the Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0135] Example 2-2. Construction of a vector for introducing Pm4tkt_tkt into Corynebacterium glutamicum ATCC13869 A vector was prepared for introducing a copy of the tkt gene with a variant of the Pm4tkt promoter (SEQ ID NO: 2) into Corynebacterium glutamicum ATCC13869.

[0136] A vector was prepared for inserting a target gene while simultaneously deleting the aroP (γ-aminobutyric acid permease, GenBank accession number WP_060564335.1) position of Corynebacterium glutamicum ATCC13869, which is a location for homologous recombination on the chromosome.

[0137] Specifically, using primer pairs SEQ ID NO: 15 and 16 and SEQ ID NO: 17 and SEQ ID NO: 18, gene fragments in the upstream and downstream regions of aroP undergoing homologous recombination on the chromosome were obtained by PCR based on the chromosomal DNA of Corynebacterium glutamicum ATCC13869. Solg™ Pfu-X polymerase was used as the polymerase, and PCR was performed under the following PCR amplification conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; then polymerization at 72°C for 5 minutes.

[0138] The upstream and downstream regions of aroP, amplified using the Gibson assembly method, along with the pDCM2 vector for chromosome transformation digested with SmaI restriction endonuclease, were cloned to obtain a recombinant plasmid named pDCM2-ΔaroP. Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0139] Using pCES208_Pm4tkt_gfp as a template, PCR was performed using primers SEQ ID NO: 19 and 20, and gene fragments with Pm4tkt promoter variants were obtained by PCR. Additionally, using Corynebacterium glutamicum ATCC13869 chromosomal DNA as a template, primers SEQ ID NO: 21 and 22 were used to obtain... tkt The gene's ORF. Solg™ Pfu-X polymerase was used as the polymerase for PCR amplification under the following conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; followed by polymerization at 72°C for 5 minutes.

[0140] Pm4tkt was cloned and amplified using the Gibson assembly method. tkt The gene and the pDCM2-ΔaroP vector for chromosome transformation, digested with the ScaI restriction endonuclease, were used to obtain a recombinant plasmid named pDCM2-ΔaroP::Pm4tkt_tkt. Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0141] In addition, to compare with the Pm4tkt promoter, a promoter based on... tkt A copy is added in the form of the gene's own promoter (Pntkt). tkt Gene vector. Specifically, using the chromosomal DNA of Corynebacterium glutamicum ATCC13869 as a template, PCR was performed using primers SEQ ID NO: 19 and 22 to obtain a vector containing... tkt Gene self-promoters tkt Genes. The obtained genes and the pDCM2-ΔaroP vector prepared above and digested with ScaI restriction endonuclease for chromosome transformation were cloned using the Gibson assembly method to obtain recombinant plasmids, the product of which was named pDCM2-ΔaroP::Pntkt_tkt. Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0142] Examples 2-3. Construction of vectors for introducing Pm4tkt promoter variants into Corynebacterium glutamicum ATCC13869 To replace the previously introduced aroP position with the Pm4tkt promoter variant tkt The natural promoter of the gene, using SEQ ID NO: 23 and 24, was used as a template in PCR with the pDCM2-ΔaroP::Pm4tkt_tkt vector prepared in Example 2-2 to obtain a gene fragment containing the Pm4tkt sequence. This gene fragment was then mixed with the pDCM2 vector digested with SmaI restriction endonuclease, and the recombinant plasmid was cloned using the Gibson assembly method. The resulting product was named pDCM2-ΔPn::Pm4tkt_tkt. Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0143] Example 3. Assessment of the production capacity of the target product 3-1. Evaluation of Lysine Production Capacity 3-1-1. Construction of L-lysine-producing strains with tkt promoter variant Strains transformed with the tkt promoter variant were prepared using the pDCM2-Pm4tkt_tkt vector prepared in Example 2-1. For this purpose, the vector was transformed into *Corynebacterium glutamicum* CJ3P (US 9556463 ​​B2), an L-lysine-producing strain, to introduce the tkt promoter variant sequence into the chromosome. Since the CJ3P strain is an L-lysine-producing *Corynebacterium glutamicum* strain, it is capable of producing L-lysine by introducing three types of mutations (pyc(P458S), hom(V59A), and lysC(T311l)) into the wild-type strain using previously known techniques.

[0144] Specifically, the vector prepared in Example 2-1 was transformed into the CJ3P strain via electroporation, and the transformed strain was obtained in a selective medium containing 25 mg / L kanamycin. Through secondary hybridization, PCR and sequencing were performed using primers SEQ ID NO: 7 and 8 to select strains that introduced the tkt promoter variant by inserting a DNA fragment into the chromosome. The selected strain was named *Corynebacterium glutamicum* CJ3P::Pm4tkt_tkt (CM03-1661) and deposited at the Korean Center for Microbial Culture Collection on April 5, 2021, under the Budapest Treaty, with accession number KCCM12971P.

[0145] 3-1-2. Evaluation of L-lysine production capacity of strains with introduced tkt promoter variants To evaluate the L-lysine production capacity of the *Corynebacterium glutamicum* CJ3P strain used as the parent strain and the *Corynebacterium glutamicum* CJ3P::Pm4tkt_tkt strain prepared in Example 3-1-1, the strains were cultured and analyzed in the following manner.

[0146] First, each strain was inoculated into a 250 mL corner-baffle flask containing 25 mL of seed culture medium and cultured at 30°C with shaking at 200 rpm for 20 hours. Then, 1 mL of seed culture was inoculated into a 250 mL corner-baffle flask containing 24 mL of production culture medium and cultured at 32°C with shaking at 200 rpm for 48 hours. The compositions of the nutrient medium, seed culture medium, and production culture medium are shown below.

[0147] Seed culture medium (pH 7.0) Glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSO4•7H2O 0.5 g, biotin 100 μg, thiamine-HCl 1000 μg, calcium pantothenate 2000 μg, nicotinamide 2000 μg (based on 1 L distilled water) <Production medium (pH 7.0)> Ingredients: 45 g glucose, 10 g soy protein, 10 g molasses, 15 g (NH4)2SO4, 0.55 g KH2PO4, 0.6 g MgSO4•7H2O, 9 mg FeSO4•7H2O, 9 mg MnSO4∙5H2O, 0.9 mg biotin, 4.5 mg thiamine-HCl, 30 g CaCO3, 4.5 mg calcium pantothenate, 30 mg nicotinamide, 0.45 mg ZnSO4, 0.45 mg CuSO4 (based on 1 L distilled water) After cultivation, L-lysine production was measured using HPLC. The L-lysine concentration and concentration increase rate of *Corynebacterium glutamicum* strains CJ3P and CJ3P::Pm4tkt_tkt in the culture medium are shown in Table 3 below.

[0148] [Table 3] As shown in Table 3, it was confirmed that the concentration of L-lysine in the CJ3P::Pm4tkt_tkt strain, which introduced the tkt promoter variant, increased by 23.82% compared with the parental strain CJ3P.

[0149] Example 3-2. Evaluation of Threonine Production Capacity 3-2-1. Construction of L-threonine-producing strains To construct strains transformed with tkt promoter variants using the pDCM2-Pm4tkt_tkt vector prepared in Example 2-1, firstly, based on the Corynebacterium glutamicum ATCC13032 strain, a vector was prepared to introduce... lysC (L377K) mutant (Korean Patent No. 10-2011994) and hom L-threonine producing strain of (R398Q) mutant (Korean Patent No. 10-1947959).

[0150] Specifically, in order to prepare an L-threonine-producing strain, a strain for introducing... lysC The vector (L377K) was prepared using primer pairs SEQ ID NO: 25 and 26 and SEQ ID NO: 27 and 28, based on the chromosome of wild-type Corynebacterium glutamicum strain ATCC13032 as a template. Solg™ Pfu-X DNA polymerase was used as the polymerase, and PCR was performed under the following PCR amplification conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; then polymerization at 72°C for 5 minutes. The amplified product and the pDCM2 vector for chromosome transformation, digested with SmaI restriction endonuclease, were cloned using the Gibson assembly method to obtain the recombinant plasmid, named pDCM2-lysC (L377K). Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts and then incubating at 50°C for 1 hour.

[0151] The pDCM2-lysC (L377K) vector prepared therefrom was introduced into *Corynebacterium glutamicum* strain ATCC13032 via electroporation, and then transformed strains were obtained in selective medium containing 25 mg / L kanamycin. Through secondary hybridization, PCR and sequencing were performed using primers SEQ ID NO: 29 and 30 to select strains that introduced nucleotide mutations by inserting DNA fragments into the chromosome. lysC The selected strain was named ATCC13032::lysC(L377K).

[0152] In addition, in order to prepare for the introduction homThe vector (R398Q), based on the chromosome of Corynebacterium glutamicum strain ATCC13032 as a template, was used for PCR with primer pairs SEQ ID NO: 31 and 32 and SEQ ID NO: 33 and 34. Solg™ Pfu-X DNA polymerase was used as the polymerase, and PCR was performed under the following PCR amplification conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; then polymerization at 72°C for 5 minutes. The amplified product and the pDCM2 vector for chromosome transformation, digested with SmaI restriction endonuclease, were cloned using the Gibson assembly method to obtain the recombinant plasmid, named pDCM2-hom (R398Q). Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts and then incubating at 50°C for 1 hour.

[0153] The pDCM2-hom (R398Q) vector prepared above was introduced into *Corynebacterium glutamicum* strain ATCC13032::lysC (L377K) via electroporation, and then transformed strains were obtained in selective medium containing 25 mg / L kanamycin. Through secondary hybridization, PCR and sequencing were performed using primers SEQ ID NO: 35 and 36 to select strains that introduced nucleotide mutations by inserting DNA fragments into the chromosome. hom The selected strain was named Corynebacterium glutamicum ATCC13032::lysC (L377K)-hom (R398Q).

[0154] 3-2-2. Construction of L-threonine-producing strains with tkt promoter variant The pDCM2-Pm4tkt_tkt vector prepared in Example 2-1 was introduced into *Corynebacterium glutamicum* strain ATCC13032::lysC(L377K)-hom(R398Q) via electroporation, and then transformed strains were obtained in selective medium containing 25 mg / L kanamycin. Through secondary hybridization, PCR and sequencing were performed using primers SEQ ID NO: 7 and 8 to select strains that introduced the tkt promoter variant by inserting a DNA fragment onto the chromosome. The selected strains were named *Corynebacterium glutamicum* ATCC13032::lysC(L377K)-hom(R398Q)-Pm4tkt_tkt.

[0155] 3-2-3. Evaluation of L-threonine production capacity of strains with introduced tkt promoter variants To evaluate the L-threonine production capacity of *Corynebacterium glutamicum* ATCC13032::lysC(L377K)-hom(R398Q) used as the parent strain and ATCC13032::lysC(L377K)-hom(R398Q)-Pm4tkt_tkt prepared in Example 3-2-2, the strains were cultured and analyzed in the following manner.

[0156] First, each strain was inoculated into a 250 mL angle-baffle flask containing 25 mL of seed culture medium and cultured at 30°C with shaking at 200 rpm for 20 hours. Then, 1 mL of seed culture was inoculated into a 250 mL angle-baffle flask containing 24 mL of production culture medium and cultured at 32°C with shaking at 200 rpm for 48 hours. The compositions of the nutrient medium, seed culture medium, and production culture medium are shown below.

[0157] Seed culture medium (pH 7.0) Glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSO4•7H2O 0.5 g, biotin 100 μg, thiamine-HCl 1000 μg, calcium pantothenate 2000 μg, nicotinamide 2000 μg (based on 1 L distilled water) <Production medium (pH 7.0)> Ingredients: 45 g glucose, 10 g soy protein, 10 g molasses, 15 g (NH4)2SO4, 0.55 g KH2PO4, 0.6 g MgSO4•7H2O, 9 mg FeSO4•7H2O, 9 mg MnSO4∙5H2O, 0.9 mg biotin, 4.5 mg thiamine-HCl, 30 g CaCO3, 4.5 mg calcium pantothenate, 30 mg nicotinamide, 0.45 mg ZnSO4, 0.45 mg CuSO4 (based on 1 L distilled water) After cultivation, L-threonine production was measured using HPLC. The L-threonine concentrations and their increase rates in the culture medium for the *Corynebacterium glutamicum* strains ATCC13032::lysC(L377K)-hom(R398Q) and ATCC13032::lysC(L377K)-hom(R398Q)-Pm4tkt_tkt are shown in Table 4 below.

[0158] [Table 4] As shown in Table 4, compared with the parent strain ATCC13032::lysC (L377K)-hom (R398Q), the concentration of L-threonine in the ATCC13032::lysC (L377K)-hom (R398Q)-Pm4tkt_tkt strain, which introduced the tKt promoter variant, increased by 41.30%.

[0159] Example 3-3. Evaluation of O-acetylhomoserine production capacity 3-3-1. Construction of O-acetylhomoserine producing strains with tkt promoter variant The pDCM2-Pm4tkt_tkt vector prepared in Example 2-1 was introduced into wild-type Corynebacterium glutamicum ATCC13032 via electroporation, and then transformed strains were obtained in selective medium containing 25 mg / L kanamycin. Through secondary hybridization, PCR and sequencing were performed using primers SEQ ID NO: 7 and 8 to select strains that introduced the tkt promoter variant by inserting a DNA fragment onto the chromosome. The selected strains were named Corynebacterium glutamicum ATCC13032::Pm4tkt_tkt.

[0160] 3-3-2. Evaluation of O-acetylhomoserine production capacity with the introduction of tkt promoter variants To evaluate the O-acetylhomoserine production capacity of Corynebacterium glutamicum ATCC13032, which was used as the parent strain, and ATCC13032::Pm4tkt_tkt prepared in Example 3-3-1, the strains were cultured and analyzed in the following manner.

[0161] The strain was inoculated into a 250 mL angle baffle flask containing less than 25 mL of culture medium using an inoculation loop, and then cultured at 33°C with shaking at 200 rpm for 20 hours.

[0162] <Production medium (pH 7.2)> Glucose 30 g, KH2PO4 2 g, urea 3 g, (NH4)2SO4 40 g, peptone 2.5 g, CSL (corn steep liquor, Sigma) 5 g (10 mL), MgSO4∙7H2O 0.5 g, CaCO3 20 g (based on 1 L distilled water) After cultivation, the O-acetylhomoserine production capacity was measured by HPLC. The concentrations and concentration increases of O-acetylhomoserine in the culture medium for Corynebacterium glutamicum strains ATCC13032 and ATCC13032::Pm4tkt_tkt are shown in Table 5 below.

[0163] [Table 5] As shown in Table 5, it was confirmed that the concentration of O-acetylhomoserine in the ATCC13032::Pm4tkt_tkt strain, which introduced the tkt promoter variant, increased by 46.43% compared with the parental wild-type ATCC13032 strain.

[0164] Examples 3-4. Evaluation of isoleucine production capacity 3-4-1. Construction of L-isoleucine-producing strains with tkt promoter variant To prepare strains transformed with tkt promoter variants using the pDCM2-Pm4tkt_tkt vector prepared in Example 2-1, the vector was first transformed into *Corynebacterium glutamicum* CJP1 (Korean Patent No. 10-1996769), and then the tkt promoter variant sequence was introduced into its chromosome. Subsequently, strains containing... ilvA The vector of gene (V323A) Appl. Enviro. Microbiol. (December 1996, pp. 4345-4351)) thereby preparing an L-isoleucine-producing strain (Korean Patent No. 10-1996769), which encodes a previously known L-threonine dehydratase. ilvA The 323rd amino acid in the gene, valine, was mutated to alanine.

[0165] Specifically, the pDCM2-Pm4tkt_tkt vector prepared in Example 2-1 was introduced into the CJP1 strain via electroporation, and then transformed strains were obtained in a selection medium containing 25 mg / L kanamycin. Through secondary hybridization, PCR and sequencing were performed using primers SEQ ID NO: 7 and 8 to select strains that introduced the tkt promoter variant by inserting a DNA fragment onto the chromosome. The selected strains were named *Corynebacterium glutamicum* CJP1::Pm4tkt_tkt.

[0166] The pECCG117-ilvA (V323A) vector was introduced into the CJP1::Pm4tkt_tkt and CJP1 strains prepared above, respectively, and then transformed strains were obtained in selective medium containing 25 mg / L kanamycin. The selected strains were named Corynebacterium glutamicum CJP1 / pECCG117-ilvA (V323A) and CJP1::Pm4tkt_tkt / pECCG117-ilvA (V323A), respectively.

[0167] 3-4-2. Evaluation of L-isoleucine production capacity of strains with introduced tkt promoter variants To evaluate the L-isoleucine production capacity of the Corynebacterium glutamicum strains CJP1 / pECCG117-ilvA (V323A) and CJP1::Pm4tkt_tkt / pECCG117-ilvA (V323A) used as parent strains, the strains were cultured and analyzed in the following manner.

[0168] First, each strain was inoculated into a 250 mL angle-baffle flask containing 25 mL of seed culture medium and cultured at 30°C with shaking at 200 rpm for 20 hours. Then, 1 mL of seed culture was inoculated into a 250 mL angle-baffle flask containing 24 mL of production culture medium and cultured at 32°C with shaking at 200 rpm for 48 hours. The compositions of the nutrient medium, seed culture medium, and production culture medium are shown below.

[0169] Seed culture medium (pH 7.0) Glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSO4•7H2O 0.5 g, biotin 100 μg, thiamine-HCl 1000 μg, calcium pantothenate 2000 μg, nicotinamide 2000 μg (based on 1 L distilled water) <Production medium (pH 7.0)> Ingredients: 45 g glucose, 10 g soy protein, 10 g molasses, 15 g (NH4)2SO4, 0.55 g KH2PO4, 0.6 g MgSO4•7H2O, 9 mg FeSO4•7H2O, 9 mg MnSO4∙5H2O, 0.9 mg biotin, 4.5 mg thiamine-HCl, 30 g CaCO3, 4.5 mg calcium pantothenate, 30 mg nicotinamide, 0.45 mg ZnSO4, 0.45 mg CuSO4 (based on 1 L distilled water) After cultivation, L-isoleucine production was measured using HPLC. The L-isoleucine concentrations and concentration increases of Corynebacterium glutamicum CJP1 / pECCG117-ilvA (V323A) and CJP1::Pm4tkt_tkt / pECCG117-ilvA (V323A) strains in the culture medium are shown in Table 6 below.

[0170] [Table 6] As shown in Table 6, it was confirmed that the L-isoleucine concentration of the CJP1::Pm4tkt_tkt / pECCG117-ilvA (V323A) strain with the tkt promoter variant increased by 57.35% compared with the CJP1 / pECCG117-ilvA (V323A) strain.

[0171] Examples 3-5. Evaluation of tryptophan production capacity 3-5-1. Construction of L-tryptophan-producing strains To confirm the effectiveness of the Pm4tkt promoter variant, an L-tryptophan-producing strain was first prepared based on the wild-type Corynebacterium glutamicum ATCC13869 strain.

[0172] Specifically, the expression of the L-tryptophan biosynthesis gene operon is enhanced via promoter enhancement. Additionally, to relieve feedback inhibition of the TrpE protein, the 38th amino acid serine of trpE is replaced with arginine. JOURNAL OF BACTERIOLOGY , Nov. 1987, pp. 5330-5332).

[0173] For genetic manipulation, the upstream and downstream regions of the trpE promoter, where homologous recombination occurs, were first obtained on the chromosome. Specifically, using chromosomal DNA from Corynebacterium glutamicum ATCC13869 as a template, PCR was performed using primers SEQ ID NO: 37 and 38 to obtain the gene fragment of the upstream region of the trpE promoter, and primers SEQ ID NO: 41 and 42 to obtain the gene fragment of the downstream region. Additionally, PCR was performed using primers SEQ ID NO: 39 and 40, based on the synthesized promoter SPL7 (Korean Patent No. 10-1783170) and the trpE(S38R) sequence (SEQ ID NO: 43) as templates. Solg™ Pfu-X DNA polymerase was used as the polymerase, and PCR was performed under the following PCR amplification conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 58°C for 30 seconds, and polymerization at 72°C for 60 seconds; then polymerization at 72°C for 5 minutes.

[0174] Three amplification products and the pDCM2 vector for chromosome transformation, digested with the SmaI restriction endonuclease, were cloned using the Gibson assembly method to obtain recombinant plasmids, which were named pDCM2-PSPL7_trpE (S38R). Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts and then incubating at 50°C for 1 hour.

[0175] The pDCM2-PSPL7_trpE (S38R) vector prepared above was introduced into wild-type *Corynebacterium glutamicum* strain ATCC13869 via electroporation, and then transformed into strains in selective medium containing 25 mg / L kanamycin. Through secondary hybridization, strains were obtained in which the promoter of trpE was replaced by the stronger SPL7 promoter on the chromosome, and the serine residue at position 38 of trpE was replaced by arginine. The corresponding genetic manipulation was confirmed by genome sequencing and PCR using SEQ ID NO: 44 and 45, which amplified the upstream and downstream regions of homologous recombination of the inserted gene. The resulting product was named *Corynebacterium glutamicum* ATCC13869::PSPL7_trpE (S38R).

[0176] 3-5-2. Construction of an L-tryptophan-producing strain with one copy of the tkt gene Tryptophan production occurs via the aromatic amino acid metabolic pathway, which begins with the condensation reaction between phosphoenolpyruvate and erythrose 4-phosphate. Therefore, an adequate supply of these two precursors is essential for enhancing tryptophan production, and overexpression of the tkt gene is indispensable for an adequate supply of erythrose 4-phosphate, which is known to be relatively scarce. Therefore, L-tryptophan-producing strains were prepared using pDCM2-ΔaroP, pDCM2-ΔaroP::Pm4tkt_tkt, and pDCM2-ΔaroP::Pntkt_tkt prepared in Examples 2-2.

[0177] The three vectors described above were introduced into the *Corynebacterium glutamicum* ATCC13869::PSPL7_trpE (S38R) strain prepared in Example 3-5-1, and transformed strains were obtained in a selective medium containing 25 mg / L kanamycin. Through secondary hybridization, strains lacking the specified vectors were obtained. aroP Or inserted at the aroP site on the chromosome. Pntkt_tkt Genes and Pm4tkt_tkt The strains from which the genes were derived were identified. The corresponding genetic manipulations were confirmed by genome sequencing and PCR using SEQ ID NO: 46 and 47, and the strains obtained were named ATCC13869::PSPL7_trpE (S38R)ΔaroP, ATCC13869::PSPL7_trpE (S38R)ΔaroP::Pntkt_tkt, and ATCC13869::PSPL7_trpE (S38R)ΔaroP::Pm4tkt_tkt, respectively.

[0178] 3-5-3. Evaluation of L-tryptophan production capacity of strains in which a single copy of the tkt gene has been introduced. To evaluate the Corynebacterium glutamicum strains used as parents, including ATCC13869::PSPL7_trpE (S38R) and the strains prepared in Examples 3-5-2, namely ATCC13869::PSPL7_trpE (S38R)ΔaroP, ATCC13869::PSPL7_trpE (S38R)ΔaroP::Pntkt_tkt, and ATCC13869::PSPL7_trpE (S38R)ΔaroP::Pm4tkt_tkt, the strains were cultured and analyzed as follows.

[0179] First, each strain was inoculated into a 250 mL angle-baffle flask containing 25 mL of seed culture medium and cultured at 30°C with shaking at 200 rpm for 20 hours. Then, 1 mL of seed culture was inoculated into a 250 mL angle-baffle flask containing 24 mL of production culture medium and cultured at 32°C with shaking at 200 rpm for 48 hours. The compositions of the nutrient medium, seed culture medium, and production culture medium are shown below.

[0180] Seed culture medium (pH 7.0) Glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSO4•7H2O 0.5 g, biotin 100 μg, thiamine-HCl 1000 μg, calcium pantothenate 2000 μg, nicotinamide 2000 μg (based on 1 L distilled water) <Production medium (pH 7.0)> 30 g glucose, 15 g (NH4)2SO4, 1.2 g MgSO4 7H2O, 1 g KH2PO4, 5 g yeast extract, 900 μg biotin, 4500 μg thiamine-HCl, 4500 μg calcium pantothenate, 30 g CaCO3 (based on 1 L distilled water).

[0181] After cultivation, L-tryptophan production was measured using HPLC. The L-tryptophan concentrations and their increase rates in the culture medium for the following strains of Corynebacterium glutamicum: ATCC13869::PSPL7_trpE (S38R), ATCC13869::PSPL7_trpE (S38R)ΔaroP, ATCC13869::PSPL7_trpE (S38R)ΔaroP::Pntkt_tkt, and ATCC13869::PSPL7_trpE (S38R)ΔaroP::Pm4tkt_tkt are shown in Table 7 below.

[0182] [Table 7] As shown in Table 7, it was confirmed that one copy of [a specific substance] was introduced compared to the control strain ATCC13869::PSPL7_trpE (S38R)ΔaroP. Pm4tkt_tkt The L-tryptophan concentration in the ATCC13869::PSPL7_trpE (S38R)ΔaroP::Pm4tkt_tkt strain increased by 62.50%.

[0183] Examples 3-6. Evaluation of tyrosine production capacity 3-6-1. Construction of L-tyrosine-producing strains To confirm the effectiveness of the Pm4tkt promoter variant, L-tyrosine-producing strain CM06-0010 (Korean Patent No. 10-2134418, deposited at the Korean Microbiological Collection Center, accession number KCCM12487P) was used as the parent strain for transformation.

[0184] Specifically, the pDCM2-ΔPn::Pm4tkt_tkt vector prepared in Examples 2-3 was introduced into strain CM06-0010 via electroporation, and then transformed strains were obtained in selective medium containing 25 mg / L kanamycin. Through secondary hybridization, strains in which the natural tkt promoter (Pntkt) was replaced by a DNA fragment inserted into the chromosome with a tkt promoter variant were obtained. The corresponding genetic manipulation was confirmed by genome sequencing and PCR using SEQ ID NO: 48 and 49, and the strain thus prepared was named CM06-0010ΔPn::Pm4tkt_tkt.

[0185] 3-6-2. Evaluation of L-tyrosine production capacity of strains with introduced tkt promoter variants To evaluate the L-tyrosine production capacity of *Corynebacterium glutamicum* CM06-0010 used as the parent strain and CM06-0010ΔPn::Pm4tkt_tkt prepared in Example 3-6-1, the strains were cultured and analyzed in the following manner.

[0186] First, each strain was inoculated into a 250 mL angle-baffle flask containing 25 mL of seed culture medium and cultured at 30°C with shaking at 200 rpm for 20 hours. Then, 1 mL of seed culture was inoculated into a 250 mL angle-baffle flask containing 24 mL of production culture medium and cultured at 32°C with shaking at 200 rpm for 48 hours. The compositions of the nutrient medium, seed culture medium, and production culture medium are shown below.

[0187] Seed culture medium (pH 7.0) Glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSO4•7H2O 0.5 g, biotin 100 μg, thiamine-HCl 1000 μg, calcium pantothenate 2000 μg, nicotinamide 2000 μg (based on 1 L distilled water) <Production medium (pH 7.0)> Glucose 30 g, (NH4)2SO4 15 g, MgSO4 7H2O 1.2 g, KH2PO4 1 g, yeast extract 5 g, biotin 900 μg, thiamine-HCl 4500 μg, calcium pantothenate 4500 μg, CaCO3 30 g (based on 1 L distilled water) After cultivation, L-tyrosine production was measured using HPLC. The L-tyrosine concentration and concentration increase rate of strains CM06-0010 and CM06-0010ΔPn::Pm4tkt_tkt in the culture medium are shown in Table 8 below.

[0188] [Table 8] As shown in Table 8, the Pm4tkt variant was used to replace the control strain CM06-0010, which confirmed the difference. tkt The concentration of L-tyrosine in the CM06-0010ΔPn::Pm4tkt_tkt strain, the natural promoter of the gene, increased by 42.29%.

[0189] Examples 3-7. Evaluation of phenylalanine production capacity 3-7-1. Construction of L-phenylalanine producing strains To confirm the effectiveness of the Pm4tkt promoter variant, an L-phenylalanine-producing strain was first prepared based on the wild-type Corynebacterium glutamicum ATCC13869 strain (see Korean Patent No. 10-2134418).

[0190] Specifically, those subject to L-tyrosine feedback regulation tyrA The gene was replaced with an E. coli-derived gene that does not accept feedback regulation, including a strong gapA promoter. tyrA Variant. It is known that in the *E. coli*-derived tyrA protein, feedback is deactivated when methionine at position 53 is mutated to isoleucine and alanine at position 354 is mutated to valine, and this form of the protein (SEQ ID NO: 50) is used. Appl. Microbiol. Biotechnol. 75, 103-110 (2007)).

[0191] For genetic operations, the first step is to obtain the data that needs to be processed through replacement and insertion.tyrA Genetic tyrA The upstream and downstream regions of the gene. Specifically, based on the chromosomal DNA of Corynebacterium glutamicum ATCC13869 as a template, PCR was performed using primers SEQ ID NO: 51 and 52 to obtain... tyrA Gene fragments in the upstream region of the gene were obtained using primers of SEQ ID NO: 53 and 54. tyrA Gene fragments in the downstream region of the gene. Additionally, to obtain E. coli variants containing the gapA promoter. tyrA Genes were obtained using chromosomal DNA from Corynebacterium glutamicum ATCC13869 as a template. The gapA promoter fragment, based on a variant derived from E. coli, was obtained by PCR using primers SEQ ID NO: 55 and 56. tyrA Using synthetic DNA (SEQ ID NO: 50) as a template, a variant derived from *E. coli* was obtained by PCR using primers of SEQ ID NO: 57 and 58. tyrA Gene fragments. Solg™ Pfu-X DNA polymerase was used as the polymerase for PCR amplification under the following conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 60°C for 30 seconds, and polymerization at 72°C for 60 seconds; followed by polymerization at 72°C for 5 minutes.

[0192] Cloning and amplification using the Gibson assembly method tyrA Upstream and downstream regions, gapA promoter, E. coli-derived variants tyrA Gene fragments and the pDCM2 vector for chromosome transformation, digested with SmaI restriction endonuclease, were used to obtain recombinant plasmids, named pDCM2-ΔtyrA::PgapA-tyrAm. Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0193] The pDCM2-ΔtyrA::PgapA-tyrAm vector prepared in this manner was transformed into wild-type Corynebacterium glutamicum ATCC13869 via electroporation, followed by secondary hybridization to obtain E. coli-derived variants containing the inserted gapA promoter. tyrA Genes, simultaneously missing tyrA The strain from which the gene was obtained was confirmed by genome sequencing and PCR using primers of SEQ ID NO: 59 and 60. The resulting strain was named ATCC13869ΔtyrA::PgapA-tyrAm.

[0194] Relieve variants through feedback regulation from E. coli source aroGThe addition of a strong promoter enhances its participation in the first step of the universal aromatic biosynthetic pathway. aroG Gene. It is known that in the aroG protein derived from *E. coli*, feedback is relieved when proline at position 150 is replaced by leucine, and this form of protein (SEQ ID NO: 61) is used. Appl. Environ. Microbiol. 63, 761-762 (1997)).

[0195] For genetic operations, further insertions were obtained. aroG The upstream and downstream regions of the gene. Specifically, the vector was prepared using the BBD29_14470 position, which is one of the transposases of Corynebacterium glutamicum that undergoes homologous recombination on the chromosome.

[0196] Specifically, using chromosomal DNA from *Corynebacterium glutamicum* ATCC13869 as a template, PCR was performed using primers SEQ ID NO: 62 and 63 to obtain the gene fragment upstream of the BBD29_14470 gene, and primers SEQ ID NO: 64 and 65 to obtain the gene fragment downstream of the BBD29_14470 gene. Additionally, to obtain a variant from *E. coli* containing the gapA promoter... aroG Genes were obtained using chromosomal DNA from Corynebacterium glutamicum ATCC13869 as a template. The gapA promoter fragment was obtained by PCR using primers SEQ ID NO: 66 and 67, and a feedback release variant from Escherichia coli was also obtained. aroG Using synthetic DNA (SEQ ID NO: 61) as a template, E. coli-derived variants were obtained by PCR using primers of SEQ ID NO: 68 and 69. aroG Gene fragments. Solg™ Pfu-X DNA polymerase was used as the polymerase for PCR amplification under the following conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles: denaturation at 95°C for 30 seconds, annealing at 60°C for 30 seconds, and polymerization at 72°C for 60 seconds; followed by polymerization at 72°C for 5 minutes.

[0197] Upstream and downstream regions of the BBD29_14470 gene, the gapA promoter, and E. coli-derived variants were cloned and amplified using the Gibson assembly method. aroG Gene fragments and the pDCM2 vector for chromosome transformation, digested with SmaI restriction endonuclease, were used to obtain recombinant plasmids, which were named pDCM2-ΔBBD29_14470::PgapA-aroGm. Cloning was performed by mixing Gibson assembly reagent and each gene fragment in calculated molar amounts, followed by incubation at 50°C for 1 hour.

[0198] The pDCM2-ΔBBD29_14470::PgapA-aroGm vector prepared in this manner was transformed into the ATCC13869ΔtyrA::PgapA-tyrAm strain via electroporation, followed by secondary hybridization to obtain a feedback-relief variant derived from E. coli with an inserted gapA promoter. aroG The strain from which the gene was obtained. The corresponding genetic manipulation was confirmed by genome sequencing and PCR using primers of SEQ ID NO: 70 and 71, and the resulting strain was named ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGm.

[0199] 3-7-2. Construction of an L-phenylalanine-producing strain with a single copy of the tkt gene inserted. L-phenylalanine-producing strains were prepared using pDCM2-ΔaroP, pDCM2-ΔaroP::Pm4tkt_tkt, and pDCM2-ΔaroP::Pntkt_tkt prepared in Example 2-2. These three vectors were introduced into the ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGm strain prepared in Example 3-7-1 via electroporation, and then transformed strains were obtained in a selective medium containing 25 mg / L kanamycin. Through secondary hybridization, strains with the deletions of specific molecules were obtained. aroP Or inserted at the aroP site on the chromosome Pntkt_tkt Genes and Pm4tkt_tkt Strains containing the gene. The corresponding genetic operations were confirmed by genome sequencing and PCR using SEQ ID NO: 46 and 47. The strains prepared were named ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaro, ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP::Pntkt_tkt, and ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP::Pm4tkt_tkt, respectively.

[0200] 3-7-3. Evaluation of L-phenylalanine production capacity of strains with a single copy of the tkt gene inserted. To evaluate the L-phenylalanine production capacity of the *Corynebacterium glutamicum* strains ATCC13869ΔtyrA::PgapA-tyrAm ΔBBD29_14470::PgapA-aroGm and the strains ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP, ATCC13869ΔtyrA::PgapA-tyrAm ΔBBD29_14470::PgapA-aroGmΔaroP::Pntkt_tkt, and ATCC13869ΔtyrA::PgapA-tyrAm ΔBBD29_14470::PgapA-aroGmΔaroP::Pm4tkt_tkt prepared in Example 3-7-2, the strains were cultured and analyzed as follows.

[0201] First, each strain was inoculated into a 250 mL angle-baffle flask containing 25 mL of seed culture medium and cultured at 30°C with shaking at 200 rpm for 20 hours. Then, 1 mL of seed culture was inoculated into a 250 mL angle-baffle flask containing 24 mL of production culture medium and cultured at 32°C with shaking at 200 rpm for 48 hours. The compositions of the nutrient medium, seed culture medium, and production culture medium are shown below.

[0202] Seed culture medium (pH 7.0) Glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSO4•7H2O 0.5 g, biotin 100 μg, thiamine-HCl 1000 μg, calcium pantothenate 2000 μg, nicotinamide 2000 μg (based on 1 L distilled water) <Production medium (pH 7.0)> 30 g glucose, 15 g (NH4)2SO4, 1.2 g MgSO4 7H2O, 1 g KH2PO4, 5 g yeast extract, 900 μg biotin, 4500 μg thiamine-HCl, 4500 μg calcium pantothenate, 30 g CaCO3 (based on 1 L distilled water).

[0203] After cultivation, L-phenylalanine production was measured using HPLC. The L-phenylalanine concentrations and their increase rates in the culture medium for strains ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGm, ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP, ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP::Pntkt_tkt, and ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP::Pm4tkt_tkt are shown in Table 9 below.

[0204] [Table 9] As shown in Table 9, it was confirmed that compared with the control strain ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP, this strain introduced one copy of... Pm4tkt_tkt The concentration of L-phenylalanine increased by 39.05% in the ATCC13869ΔtyrA::PgapA-tyrAmΔBBD29_14470::PgapA-aroGmΔaroP::Pm4tkt_tkt strain.

[0205] Based on the above results, recombinant microorganisms containing promoter-active polynucleotides of this application increase the production of L-lysine, L-threonine, O-acetylhomoserine, L-isoleucine, and aromatic amino acids such as L-tryptophan, L-tyrosine, and L-phenylalanine, which is industrially useful.

[0206] In summary, those skilled in the art will understand that this application can be implemented in other specific forms without altering its technical concept or essential characteristics. In this regard, the exemplary embodiments disclosed herein are for illustrative purposes only and should not be construed as limiting the scope of this application. Therefore, the scope of this application is indicated by the appended claims rather than by the foregoing description. All variations falling within the meaning and equivalence of the claims should be included within the scope of this application. <110> CJ Daiichi Sugar Co., Ltd. <120> Promoters and their uses <130> OPA21347 <150> KR 10-2021-0064855 <151> 2021-05-20 <160> 71 <170> KoPatentIn 3.0 <210> 1 <211> 300 <212> DNA <213> Unknown <220> <223> Promoter <400> 1 gcttgccgaa catttttctt ttcctttcgg tttttcgaga attttcacct acaaaagccc 60 acgtcacagc tcccagactt aagattgatc acacctttga cacatttgaa ccacagttgg 120 ttataaaatg ggttcaacat cactatggtt agaggtgttg acgggtcaga ttaagcaaag 180 actactttcg gggtagatca cctttgccaa atttgaacca attaacctaa gtcgtagatc 240 tgatcatcgg atctaacgaa aacgaaccaa aactttggtc ccggtttaac ccaggaagga 300 300 <210> 2 <211> 300 <212> DNA <213> Unknown <220> <223> Promoter variant <400> 2 gcttgccgaa catttttctt ttcctttcgg tttttcgaga attttcacct acaaaagccc 60 acgtcacagc tcccagactt aagattgatc acacctttga cacatttgaa ccacagttgg 120 ttataaaatg ggttcaacat cactatggtt agaggtgttg acgggtcaga ttaagcaaag 180 actactttcg gggtagatca cctttgccaa atttgaatgt ggtatcataa gtcgtagatc 240 tgatcatcgg atctaacgaa aacgaaccaa aactttggtc ccggtttaac ccaggaagga 300 300 <210> 3 <211> 37 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 3 ctctagaact agtggatccg cttgccgaac atttttc 37 <210> 4 <211> 37 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 4 gttcttctcc tttactcatt ccttcctggg ttaaacc 37 <210> 5 <211> 37 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 5 ggtttaaccc aggaaggaat gagtaaagga gaagaac 37 <210> 6 <211> 39 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 6 cccccctcga ggtcgactta tttgtagagc tcatccatg 39 <210> 7 <211> 18 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 7 gcttgccgaa catttttc 18 <210> 8 <211> 18 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 8 tccttcctgg gttaaacc 18 <210> 9 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 9 tgaattcgag ctcggtaccc ccgcacccat ccagcc 36 <210> 10 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 10 gaaaaatgtt cggcaagcaa tacggtgcaa cgtcaa 36 <210> 11 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 11 ttgacgttgc accgtattgc ttgccgaaca tttttc 36 <210> 12 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 12 cagcgtcaag gtggtcaatc cttcctgggt taaacc 36 <210> 13 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 13 ggtttaaccc aggaaggatt gaccaccttg acgctg 36 <210> 14 <211> 38 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 14 gtcgactcta gaggatcccc ggtcgcttgg tgtccttc 38 <210> 15 <211> 32 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 15 cggtacccgg ggatccctgg accacgatcg cc 32 <210> 16 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 16 taatttctat cggcctaagt actgtatcaa ccgtaaaccc 40 <210> 17 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 17 gggtttacgg ttgatacagt acttaggccg atagaaatta 40 <210> 18 <211> 32 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 18 atgcctgcag gtcgacgagg ccgtttgagc cc 32 <210> 19 <211> 37 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 19 ttacggttga tacagtactg cttgccgaac atttttc 37 <210> 20 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 20 cagcgtcaag gtggtcaatc cttcctgggt taaacc 36 <210> twenty one <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> twenty one ggtttaaccc aggaaggatt gaccaccttg acgctg 36 <210> twenty two <211> 37 <212> DNA <213> Artificial sequence <220> <223> Primers <400> twenty two tctatcggcc taagtacttt aaccgttaat ggagtcc 37 <210> twenty three <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> twenty three tgaattcgag ctcggtaccc ggagctgctg tccaacgtgg 40 <210> twenty four <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> twenty four gtcgactcta gaggatcccc tgggaacttg tcgacgctat 40 <210> 25 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 25 tgaattcgag ctcggtaccc tccaagattt tggtgctgcg 40 <210> 26 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 26 atctcagagg tggaaatctt ttcgatgttc acgttgacat 40 <210> 27 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 27 atgtcaacgt gaacatcgaa aagatttcca cctctgagat 40 <210> 28 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 28 gtcgactcta gaggatcccc gttcacctca gagacgatta 40 <210> 29 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 29 tcctaatgca cagaagctgg 20 <210> 30 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 30 gtggtgcagt tagggttcgc 20 <210> 31 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 31 tgaattcgag ctcggtaccc tttccacacc cgtgttaccg 40 <210> 32 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 32 atcatcgcgc tcttcctgtt ggattgtacg caggggatt 40 <210> 33 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 33 aatctccctg cgtacaatcc aacaggaaga gcgcgatgat 40 <210> 34 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 34 gtcgactcta gaggatcccc aaccattagc tgcagcaaca 40 <210> 35 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 35 atccaactgc agacgtcgaa 20 <210> 36 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 36 atctgggtgg ccttcaaagg 20 <210> 37 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 37 tgaattcgag ctcggtaccc ggcgttcttg cagtcc 36 <210> 38 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 38 ttgttgacat gaagcgccgg ggcacctacc gaggaa 36 <210> 39 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 39 ttcctcggta ggtgccccgg cgcttcatgt caacaa 36 <210> 40 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 40 gcgcaccgaa ctcttcaaca ccgcgaggga agaaat 36 <210> 41 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primer <400> 41 atttcttccc tcgcggtgtt gaagagttcg gtgcgc 36 <210> 42 <211> 37 <212> DNA <213> Artificial sequence <220> <223> Primer <400> 42 gtcgactcta gaggatcccc gggtacagct gcagctc 37 <210> 43 <211> 450 <212> DNA <213> Artificial sequence <220> <223> trpE(S38R) promoter seq. <400> 43 ggcgcttcat gtcaacaatc tttaacgttt tcaagttcac aagtcgtgtt caaatggtga 60 caagattgga cactgtgctg aattggcacc aagccctcat aaatgataga tctaaatcga 120 atatcaatat atggtctgtt tattggaacg cgtcccagtg gctgagacgc atccgctaaa 180 gccccaggaa ccctgtgcag aaagaacaaa taatcgtgaa ttttggcagc aacagcaatt 240 cctgctacaa ttgaaaacgt gcaaaagcat agattattgg aggagatcaa aacaatgagc 300 acgaatcccc atgttttctc cctagatgtc cgctatcacg aggatgcttc tgcgttgttt 360 gcccacttgg gtggcacaac cgcagatgat gcagccctgt tggaacgcgc tgatatcacc 420 accaagaatg gtatttcttc cctcgcggtg 450 <210> 44 <211> 16 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 44 ggcagagcat catacc 16 <210> 45 <211> 18 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 45 ggcatcagtg cgcatatc 18 <210> 46 <211> 16 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 46 ctggaccacg atcgcc 16 <210> 47 <211> 16 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 47 gaggccgttt gagccc 16 <210> 48 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 48 ggagctgctg tccaacgtgg 20 <210> 49 <211> 20 <212> DNA <213> Artificial sequence <220> <223> Primer <400> 49 tgggaacttg tcgacgctat 20 <210> 50 <211> 1122 <212> DNA <213> Unknown <220> <223> tyrA gene <400> 50 atggttgctg aattgaccgc attacgcgat caaattgatg aagtcgataa agcgctgctg 60 aatttattag cgaagcgtct ggaactggtt gctgaagtgg gcgaggtgaa aagccgcttt 120 ggactgccta tttatgttcc ggagcgcgag gcatctattt tggcctcgcg tcgtgcagag 180 gcggaagctc tgggtgtacc gccagatctg attgaggatg ttttgcgtcg ggtgatgcgt 240 gaatcttact ccagtgaaaa cgacaaagga tttaaaacac tttgtccgtc actgcgtccg 300 gtggttatcg tcggcggtgg cggtcagatg ggacgcctgt tcgagaagat gctgaccctc 360 tcgggttatc aggtgcggat tctggagcaa catgactggg atcgagcggc tgatattgtt 420 gccgatgccg gaatggtgat tgttagtgtg ccaatccacg ttactgagca agttattggc 480 aaattaccgc ctttaccgaa agattgtatt ctggtcgatc tggcatcagt gaaaaatggg 540 ccattacagg ccatgctggt ggcgcatgat ggtccggtgc tggggctaca cccgatgttc 600 ggtccggaca gcggtagcct ggcaaagcaa gttgtggtct ggtgtgatgg acgtaaaccg 660 gaagcatacc aatggttct ggagcaaatt caggtctggg gcgctcggct gcatcgtatt 720 agcgccgtcg agcacgatca gaatatggcg tttattcagg cactgcgcca ctttgctact 780 tttgcttacg ggctgcacct ggcagaagaa aatgttcagc ttgagcaact tctggcgctc 840 tcttcgccga tttaccgcct tgagctggcg atggtcgggc gactgtttgc tcaggatccg 900 cagcttatg ccgacatcat tatgtcgtca gagcgtaatc tggcgttaat caaacgttac 960 tataagcgtt tcggcgaggc gattgagttg ctggagcagg gcgataagca ggcgtttatt 1020 gacagtttcc gcaaggtgga gcactggttc ggcgattacg tgcagcgttt tcagagtgaa 1080 agccgcgtgt tattgcgtca ggcgaatgac aatcgccagt aa 1122 <210> 51 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 51 ttcgagctcg gtaccctatc aaaaccgagt tcttcc 36 <210> 52 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 52 gtcgttttta ggcctcctga caagtgtggc acatac 36 <210> 53 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 53 tgacaatcgc cagtaatttt atcggctgat gattct 36 <210> 54 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 54 actctagagg atccccaacg cgattgcatt cggctc 36 <210> 55 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 55 gtgccacact tgtcaggagg cctaaaaacg accgag 36 <210> 56 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 56 tcaattcagc aaccatgttg tgtctcctct aaagat 36 <210> 57 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 57 ttagaggaga cacaacatgg ttgctgaatt gaccgc 36 <210> 58 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 58 tcatcagccg ataaaattac tggcgattgt cattcg 36 <210> 59 <211> 16 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 59 cgcagcgagc gaaccg 16 <210> 60 <211> 18 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 60 gttcgaatcc ctccgggc 18 <210> 61 <211> 1053 <212> DNA <213> Unknown <220> <223> aroG gene <400> 61 atgaattatc agaacgacga tttacgcatc aaagaaatca aagagttact tcctcctgtc 60 gcattgctgg aaaaattccc cgctactgaa aatgccgcga atacggttgc ccatgcccga 120 aaagcgatcc ataagatcct gaaaggtaat gatgatcgcc tgttggttgt gattggccca 180 tgctcaattc atgatcctgt cgcggcaaaa gagtatgcca ctcgcttgct ggcgctgcgt 240 gaagagctga aagatgagct ggaaatcgta atgcgcgtct attttgaaaa gccgcgtacc 300 acggtgggct ggaaagggct gattaacgat ccgcatatgg ataatagctt ccagatcaac 360 gacggtctgc gtatagcccg taaattgctg cttgatatta acgacagcgg tctgccagcg 420 gcaggtgagt ttctcgatat gatcacccca caatatctcg ctgacctgat gagctggggc 480 gcaattggcg cacgtaccac cgaatcgcag gtgcaccgcg aactggcatc agggctttct 540 tgtccggtcg gcttcaaaaa tggcaccgac ggtacgatta aagtggctat cgatgccatt 600 aatgccgccg gtgcgccgca ctgcttcctg tccgtaacga aatgggggca ttcggcgatt 660 gtgaatacca gcggtaacgg cgattgccat atcattctgc gcggcggtaa agagcctaac 720 tacagcgcga agcacgttgc tgaagtgaaa gaagggctga acaaagcagg cctgccagca 780 caggtgatga tcgatttcag ccatgctaac tcgtccaaac aattcaaaaa gcagatggat 840 gtttgtgctg acgtttgcca gcagattgcc ggtggcgaaa aggccattat tggcgtgatg 900 gtggaaagcc atctggtgga aggcaatcag agcctcgaga gcggggagcc gctggcctac 960 ggtaagagca tcaccgatgc ctgcatcggc tgggaagata ccgatgctct gttacgtcaa 1020 ctggcgaatg cagtaaaagc gcgtcgcggg taa 1053 <210> 62 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primer <400> 62 ttcgagctcg gtaccccccg gcggtatcga ggtagt 36 <210> 63 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primer <400> 63 ctcggtcgtt tttaggcctc ttaatcaccc gcggggaccc 40 <210> 64 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 64 taaaagcgcg tcgcgggtaa aaacttgtcc cgagggtgag 40 <210> 65 <211> 36 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 65 actctagagg atcccctatc agtcacttcc ctgaga 36 <210> 66 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 66 gggtccccgc gggtgattaa gaggcctaaa aacgaccgag 40 <210> 67 <211> 35 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 67 gttctgataa ttcatgttgt gtctcctcta aagat 35 <210> 68 <211> 38 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 68 ctttagagga gacacaacat gaattatcag aacgacga 38 <210> 69 <211> 40 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 69 ctcaccctcg ggacaagttt ttacccgcga cgcgctttta 40 <210> 70 <211> 16 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 70 ggtaccggca ggtacc 16 <210> 71 <211> 16 <212> DNA <213> Artificial sequence <220> <223> Primers <400> 71 caagggggtc caatcc 16

Claims

1. A promoter-active polynucleotide comprising the polynucleotide sequence of SEQ ID NO: 1, wherein nucleotides at positions 218, 219, 220, 221, 222, 225, and 227 of the polynucleotide sequence of SEQ ID NO: 1 are substituted with other nucleotides, and In this substitution, nucleotide cytosine (C) at position 218 is replaced with thymine (T), nucleotide cytosine (C) at position 219 is replaced with guanine (G), nucleotide adenine (A) at position 220 is replaced with thymine (T), nucleotide adenine (A) at position 221 is replaced with guanine (G), nucleotide thymine (T) at position 222 is replaced with guanine (G), nucleotide adenine (A) at position 225 is replaced with thymine (T), and nucleotide cytosine (C) at position 227 is replaced with adenine (A).

2. A gene expression cassette comprising: the polynucleotide of claim 1; and a gene encoding a target protein operatively linked to said polynucleotide.

3. The gene expression cassette according to claim 2, wherein the target protein is a transketolase.

4. A host cell comprising: the polynucleotide of claim 1; and a gene encoding a target protein operatively linked to the polynucleotide.

5. The host cell according to claim 4, wherein the target protein is a transketolase.

6. The host cell according to claim 4, wherein the host cell is a microorganism of the genus Corynebacterium.

7. The host cell according to claim 6, wherein the Corynebacterium genus is Corynebacterium glutamicum.

8. A method for producing amino acids, comprising: Culture the host cells according to any one of claims 4-7 in a culture medium; and the amino acids were recovered from the culture medium. The amino acid is selected from at least one of lysine, threonine, O-acetylhomoserine, isoleucine, tryptophan, tyrosine, and phenylalanine.

Citation Information

Patent Citations

  • Genetically engineered l-tryptophan producing recombinant escherichia coli which has originally l-phenylalanine production character, and the method for producing l-tryptophan using the microorganism

    KR100792095B1

  • A corynebacteria having enhanced L-lysine productivity and a method of producing L-lysine using the same

    KR100924065B1

  • A novel promoter and use thereof

    KR101783170B1

  • A modified homoserine dehydrogenase and a method for producing homoserine or L- amino acid derived from homoserine using the same

    KR101947959B1

  • A homoserine dehydrogenase variant and a method for producing homoserine or L-amino acid derived from homoserine using the same

    KR101996769B1